» Articles » PMID: 31181731

CYP450s-Activity Relations of Celastrol to Interact with Triptolide Reveal the Reasons of Hepatotoxicity of

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2019 Jun 12
PMID 31181731
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Celastrol and triptolide, as the two main bio-activity ingredients in have wide anticancer pharmacological potency, as well as anti-inflammatory and immunosuppression effects. However, they have potential hepatotoxicity and underlying mechanisms of them-induced toxicity mediated by hepatic CYP450s have not been well delineated. In the present study, we accessed the toxic effects and possible mechanism of celastrol and triptolide on primary rat hepatocytes. Models of subdued/enhanced activity of CYP450 enzymes in primary rat hepatocytes were also constructed to evaluate the relationship between the two ingredients and CYP450s. LC-MS/MS was used to establish a detection method of the amount of triptolide in rat hepatocytes. As the results, cell viability, biochemical index, and mitochondrial membrane potential indicated that celastrol and triptolide had toxic potencies on hepatocytes. Moreover, the toxic effects were enhanced when the compounds combined with 1-aminobenzotriazole (enzyme inhibitor) while they were mitigated when combined with phenobarbital (an enzyme inducer). Meanwhile, celastrol could affect the amount of triptolide in the cell. We therefore put forward that increase of triptolide in the cell might be one of the main causes of hepatotoxicity caused by .

Citing Articles

PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β-Catenin Pathway.

Deng Z, Sun S, Zhou N, Peng Y, Cheng L, Yu X Adv Sci (Weinh). 2024; 12(5):e2407681.

PMID: 39656865 PMC: 11792023. DOI: 10.1002/advs.202407681.


Recent Trends in anti-tumor mechanisms and molecular targets of celastrol.

Zhu Y, Meng Y, Zhang J, Liu R, Shen S, Gu L Int J Biol Sci. 2024; 20(14):5510-5530.

PMID: 39494324 PMC: 11528459. DOI: 10.7150/ijbs.99592.


Dissection of Targeting Molecular Mechanisms of Celastrol-induced Nephrotoxicity A Combined Deconvolution Strategy of Chemoproteomics and Metabolomics.

Liu X, Zhang Q, Wang P, Peng X, An Y, Chen J Int J Biol Sci. 2024; 20(12):4601-4617.

PMID: 39309437 PMC: 11414378. DOI: 10.7150/ijbs.91751.


Hepatoma-Targeting and ROS-Responsive Polymeric Micelle-Based Chemotherapy Combined with Photodynamic Therapy for Hepatoma Treatment.

Xu X, Lu W, Zhang H, Wang X, Huang C, Huang Q Int J Nanomedicine. 2024; 19:9613-9635.

PMID: 39309184 PMC: 11414760. DOI: 10.2147/IJN.S475531.


Prodrug-inspired adenosine triphosphate-activatable celastrol-Fe(III) chelate for cancer therapy.

Li H, Li Y, Zhang L, Wang N, Lu D, Tang D Sci Adv. 2024; 10(28):eadn0960.

PMID: 38996025 PMC: 11244545. DOI: 10.1126/sciadv.adn0960.


References
1.
Stresser D, Kupfer D . Monospecific antipeptide antibody to cytochrome P-450 2B6. Drug Metab Dispos. 1999; 27(4):517-25. View

2.
Yamada H, Matsuki Y, Yamaguchi T, Oguri K . Effect of a ligand selective for peripheral benzodiazepine receptors on the expression of rat hepatic P-450 cytochromes: assessment of the effect in vivo and in a hepatocyte culture system. Drug Metab Dispos. 1999; 27(11):1242-7. View

3.
Sarkis R, Benoist S, Honiger J, Baudrimont M, Delelo R, Balladur P . Transplanted cryopreserved encapsulated porcine hepatocytes are as effective as fresh hepatocytes in preventing death from acute liver failure in rats. Transplantation. 2000; 70(1):58-64. View

4.
Donato M, Viitala P, Rodriguez-Antona C, Lindfors A, Castell J, Raunio H . CYP2A5/CYP2A6 expression in mouse and human hepatocytes treated with various in vivo inducers. Drug Metab Dispos. 2000; 28(11):1321-6. View

5.
Allison A, Cacabelos R, Lombardi V, Alvarez X, Vigo C . Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(7):1341-57. DOI: 10.1016/s0278-5846(01)00192-0. View